Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Facial Dermatoses | 3 | 2018 | 86 | 0.780 |
Why?
|
| Carcinoma, Basal Cell | 6 | 2018 | 557 | 0.680 |
Why?
|
| Dermatitis Herpetiformis | 1 | 2019 | 22 | 0.670 |
Why?
|
| Sulfasalazine | 1 | 2019 | 84 | 0.650 |
Why?
|
| Vitiligo | 1 | 2019 | 96 | 0.610 |
Why?
|
| Mohs Surgery | 3 | 2019 | 222 | 0.600 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2018 | 85 | 0.590 |
Why?
|
| Bandages | 1 | 2019 | 269 | 0.570 |
Why?
|
| Radio Waves | 1 | 2018 | 251 | 0.560 |
Why?
|
| Onychomycosis | 9 | 2001 | 50 | 0.510 |
Why?
|
| Porokeratosis | 1 | 2014 | 3 | 0.480 |
Why?
|
| Skin | 8 | 2019 | 4473 | 0.470 |
Why?
|
| Lasers, Dye | 2 | 2011 | 28 | 0.450 |
Why?
|
| Sunbathing | 1 | 2014 | 65 | 0.450 |
Why?
|
| Keratosis, Actinic | 3 | 2022 | 72 | 0.430 |
Why?
|
| Skin Neoplasms | 10 | 2021 | 5809 | 0.380 |
Why?
|
| Wound Healing | 2 | 2019 | 2801 | 0.370 |
Why?
|
| Celiac Disease | 1 | 2019 | 819 | 0.370 |
Why?
|
| Fluorouracil | 4 | 2018 | 1642 | 0.370 |
Why?
|
| Pruritus | 1 | 2014 | 378 | 0.370 |
Why?
|
| Antifungal Agents | 9 | 2001 | 753 | 0.340 |
Why?
|
| Leg Dermatoses | 1 | 2008 | 20 | 0.310 |
Why?
|
| Itraconazole | 3 | 2001 | 43 | 0.280 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2008 | 155 | 0.270 |
Why?
|
| Naphthalenes | 3 | 2001 | 198 | 0.260 |
Why?
|
| Drug Eruptions | 1 | 2008 | 335 | 0.240 |
Why?
|
| Dermatomyositis | 1 | 2008 | 258 | 0.240 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2016 | 646 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2018 | 4021 | 0.220 |
Why?
|
| Zinc Oxide | 1 | 2022 | 26 | 0.210 |
Why?
|
| Ultraviolet Therapy | 2 | 2014 | 84 | 0.190 |
Why?
|
| Melanosis | 1 | 2022 | 93 | 0.190 |
Why?
|
| Tranexamic Acid | 1 | 2022 | 172 | 0.170 |
Why?
|
| Powders | 1 | 2019 | 80 | 0.160 |
Why?
|
| Fluconazole | 4 | 2000 | 157 | 0.150 |
Why?
|
| Laser Therapy | 2 | 2016 | 1094 | 0.150 |
Why?
|
| Biopsy | 4 | 2019 | 6781 | 0.140 |
Why?
|
| Granuloma | 1 | 2019 | 327 | 0.140 |
Why?
|
| Psoriasis | 2 | 2019 | 945 | 0.140 |
Why?
|
| Chemoprevention | 1 | 2018 | 325 | 0.130 |
Why?
|
| Lasers, Gas | 1 | 2016 | 101 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2019 | 537 | 0.110 |
Why?
|
| Foot Dermatoses | 6 | 2001 | 47 | 0.100 |
Why?
|
| Mechlorethamine | 1 | 1991 | 129 | 0.100 |
Why?
|
| Dermatology | 1 | 2022 | 918 | 0.100 |
Why?
|
| Ultraviolet Rays | 2 | 2007 | 1079 | 0.100 |
Why?
|
| Epidermal Cyst | 1 | 1991 | 64 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 791 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 58946 | 0.090 |
Why?
|
| Drug Administration Schedule | 7 | 2018 | 4849 | 0.090 |
Why?
|
| Tinea Capitis | 2 | 2000 | 15 | 0.090 |
Why?
|
| Veterans | 2 | 2021 | 2652 | 0.080 |
Why?
|
| Melanoma | 2 | 2019 | 5694 | 0.080 |
Why?
|
| Male | 31 | 2022 | 360675 | 0.080 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1991 | 212 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2270 | 0.080 |
Why?
|
| Administration, Cutaneous | 3 | 2018 | 713 | 0.080 |
Why?
|
| Humans | 39 | 2022 | 761098 | 0.070 |
Why?
|
| Administration, Topical | 4 | 2015 | 703 | 0.070 |
Why?
|
| Middle Aged | 20 | 2019 | 220835 | 0.070 |
Why?
|
| Venous Insufficiency | 1 | 2008 | 108 | 0.070 |
Why?
|
| Single-Blind Method | 3 | 2016 | 1577 | 0.070 |
Why?
|
| Aged | 20 | 2021 | 169266 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12975 | 0.070 |
Why?
|
| Radiation-Protective Agents | 1 | 2006 | 88 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5494 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2017 | 2769 | 0.070 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2007 | 116 | 0.060 |
Why?
|
| Carcinoma | 1 | 2017 | 2328 | 0.060 |
Why?
|
| Treatment Outcome | 13 | 2022 | 64670 | 0.060 |
Why?
|
| Carboplatin | 1 | 2008 | 793 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 1989 | 1250 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2006 | 704 | 0.060 |
Why?
|
| Keratosis | 1 | 2004 | 79 | 0.060 |
Why?
|
| Aminolevulinic Acid | 1 | 2004 | 145 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2007 | 732 | 0.050 |
Why?
|
| Skin Diseases | 1 | 1991 | 1095 | 0.050 |
Why?
|
| Hydroquinones | 1 | 2022 | 34 | 0.050 |
Why?
|
| Fluocinolone Acetonide | 1 | 2022 | 38 | 0.050 |
Why?
|
| Leg | 2 | 2019 | 1087 | 0.050 |
Why?
|
| Skin Aging | 1 | 2004 | 140 | 0.050 |
Why?
|
| Sunlight | 1 | 2004 | 337 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5879 | 0.050 |
Why?
|
| Sunscreening Agents | 1 | 2022 | 139 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 21357 | 0.050 |
Why?
|
| Mitosporic Fungi | 1 | 2001 | 17 | 0.050 |
Why?
|
| Silicones | 1 | 2022 | 228 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2008 | 1730 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39121 | 0.040 |
Why?
|
| Female | 22 | 2022 | 392458 | 0.040 |
Why?
|
| Telemedicine | 1 | 2017 | 3051 | 0.040 |
Why?
|
| Tretinoin | 1 | 2022 | 517 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2004 | 625 | 0.040 |
Why?
|
| Nail Diseases | 1 | 1998 | 55 | 0.040 |
Why?
|
| Skin Ulcer | 1 | 2019 | 130 | 0.040 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2000 | 488 | 0.040 |
Why?
|
| Double-Blind Method | 5 | 2018 | 12341 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2016 | 1892 | 0.040 |
Why?
|
| Photochemotherapy | 1 | 2004 | 826 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2021 | 790 | 0.030 |
Why?
|
| Erythromycin | 1 | 1996 | 114 | 0.030 |
Why?
|
| Mentors | 1 | 2022 | 663 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10755 | 0.030 |
Why?
|
| New England | 1 | 2019 | 1050 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8519 | 0.030 |
Why?
|
| Necrosis | 1 | 2019 | 1611 | 0.030 |
Why?
|
| Melanins | 2 | 2007 | 289 | 0.030 |
Why?
|
| Prednisone | 1 | 2019 | 1565 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 1624 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 928 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2001 | 6305 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2019 | 1091 | 0.030 |
Why?
|
| Adult | 13 | 2019 | 221083 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1878 | 0.030 |
Why?
|
| Time Factors | 4 | 2019 | 39953 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1998 | 1315 | 0.020 |
Why?
|
| PUVA Therapy | 1 | 1991 | 101 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4853 | 0.020 |
Why?
|
| Extremities | 1 | 2016 | 867 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7405 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2021 | 80673 | 0.020 |
Why?
|
| Ontario | 2 | 2000 | 398 | 0.020 |
Why?
|
| Eccrine Glands | 1 | 2007 | 52 | 0.020 |
Why?
|
| Thymidine | 1 | 2007 | 296 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 8456 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 289 | 0.020 |
Why?
|
| Risk Factors | 5 | 2019 | 74219 | 0.020 |
Why?
|
| Child | 6 | 2017 | 80134 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11066 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13630 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10083 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2223 | 0.020 |
Why?
|
| Infant | 4 | 2017 | 36164 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2001 | 54419 | 0.010 |
Why?
|
| Thorax | 1 | 2007 | 555 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 1008 | 0.010 |
Why?
|
| Ointments | 1 | 2004 | 58 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 793 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 3450 | 0.010 |
Why?
|
| Smoking | 1 | 2000 | 9055 | 0.010 |
Why?
|
| Age Distribution | 2 | 2000 | 2873 | 0.010 |
Why?
|
| Child, Preschool | 4 | 2017 | 42217 | 0.010 |
Why?
|
| Melanocytes | 1 | 2007 | 509 | 0.010 |
Why?
|
| United States | 3 | 2021 | 72337 | 0.010 |
Why?
|
| Epidermis | 1 | 2006 | 526 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2021 | 41486 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8236 | 0.010 |
Why?
|
| Medicare | 1 | 2021 | 6775 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11118 | 0.010 |
Why?
|
| Pulse Therapy, Drug | 1 | 2001 | 37 | 0.010 |
Why?
|
| Urea | 1 | 2004 | 442 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15845 | 0.010 |
Why?
|
| Adolescent | 6 | 2017 | 88271 | 0.010 |
Why?
|
| Kinetics | 1 | 1989 | 6312 | 0.010 |
Why?
|
| Antibodies | 1 | 1989 | 2415 | 0.010 |
Why?
|
| Microsporum | 1 | 2000 | 7 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13362 | 0.010 |
Why?
|
| Lidocaine | 1 | 2004 | 538 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2017 | 26187 | 0.010 |
Why?
|
| Trichophyton | 1 | 2000 | 20 | 0.010 |
Why?
|
| Hand Dermatoses | 1 | 2000 | 62 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 2913 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 3591 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1989 | 6507 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4451 | 0.010 |
Why?
|
| Arthrodermataceae | 1 | 1998 | 7 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 2827 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 2443 | 0.010 |
Why?
|
| Bacteria, Aerobic | 1 | 1996 | 24 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29672 | 0.010 |
Why?
|
| Coagulase | 1 | 1996 | 53 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 997 | 0.010 |
Why?
|
| Staphylococcus | 1 | 1996 | 153 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24013 | 0.010 |
Why?
|
| Nails | 1 | 1998 | 296 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3461 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1996 | 255 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2000 | 2278 | 0.010 |
Why?
|
| Probability | 1 | 2000 | 2478 | 0.010 |
Why?
|
| Canada | 1 | 2000 | 2125 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 2927 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2000 | 1936 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 826 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1996 | 1073 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 1790 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10421 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18926 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2001 | 2687 | 0.010 |
Why?
|
| Health Surveys | 1 | 2000 | 4036 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59199 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2000 | 9648 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10514 | 0.000 |
Why?
|
| Boston | 1 | 1998 | 9324 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18385 | 0.000 |
Why?
|
| Prevalence | 1 | 1998 | 15717 | 0.000 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_